Literature DB >> 6605860

Rheumatoid factors and secondary immune responses in the mouse. I. Frequent occurrence of hybridomas secreting IgM anti-IgG1 autoantibodies after immunization with protein antigens.

J Van Snick, P Coulie.   

Abstract

The involvement of rheumatoid factor (RF)-secreting cells in normal immune responses was examined by screening hybridomas derived from 129/Sv mice during primary and secondary immune responses against foreign proteins. No RF-secreting cells were detected during primary responses, but up to 10% of the total number of clones obtained during secondary responses produced IgM with anti-IgG activity. Like typical mouse RF, these anti-IgG autoantibodies had a strict isotypic specificity, mostly for IgG1, and a much stronger avidity for immune complexes than for native IgG. The selective activation of IgG1-specific RF during these secondary immune reactions was not due to fortuitous antigenic similarities between mouse IgG1 and the antigens used for immunization, nor did it result from the use of adjuvants for priming, or from contamination of antigen preparations with lipopolysaccharide. It is therefore concluded that, in the 129/Sv mouse, RF production during secondary immune responses is a physiological phenomenon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605860     DOI: 10.1002/eji.1830131106

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion.

Authors:  Yasushi Miura; Charles C Chu; David M Dines; Stanley E Asnis; Richard A Furie; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

2.  Frequency and phenotypic feature of autoantibody-producing cell precursors in the preclinical stage of murine lupus.

Authors:  A Tarkowski; B Kjellson; H Carlsten; R Holmdahl; E Josefsson; C Trollmo
Journal:  Immunology       Date:  1990-11       Impact factor: 7.397

3.  Rheumatoid factors in mice bearing the lpr or gld mutation. Selective production of rheumatoid factor cryoglobulins in MRL/MPJ-lpr/lpr mice.

Authors:  T Shibata; T Berney; F Spertini; S Izui
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

Review 4.  New roles for rheumatoid factor.

Authors:  D A Carson; P P Chen; T J Kipps
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

5.  Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG.

Authors:  H Tighe; K Warnatz; D Brinson; M Corr; W O Weigle; S M Baird; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  Induction of high titers of anti-IgE by immunization of inbred mice with syngeneic IgE.

Authors:  S Haba; A Nisonoff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

7.  Experimental induction of rheumatoid factor and joint lesions in rabbits after intravenous injections of killed bacteria.

Authors:  A C Hanglow; C J Welsh; P Conn; J M Pitts; A Rampling; R R Coombs
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

8.  Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study.

Authors:  A Tarkowski; C Czerkinsky; L A Nilsson
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

9.  Spontaneous in vitro production of rheumatoid factor during infectious exacerbations of cystic fibrosis: correlation with circulating immune complex levels.

Authors:  M T Keogan; M Callaghan; G Yanni; D Mulherin; C Feighery; D L Brown; M X Fitzgerald; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

10.  Rheumatoid factors from the peripheral blood of two patients with rheumatoid arthritis are genetically heterogeneous and somatically mutated.

Authors:  K Youngblood; L Fruchter; G Ding; J Lopez; V Bonagura; A Davidson
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.